Almac Dx Opens Bioinformatics Facility to Meet Biopharma Demand
December 08, 2009
Almac Dx Opens Bioinformatics Facility to Meet Biopharma Demand
The Craigavon, UK-based company said that it opened the facility in response to an increase in the number of clinical trial-related projects it has commenced with biopharmaceutical companies.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Affymetrix's Shares Jump 30 Percent in June to Lead GWDN Index
July 1, 2011 / GenomeWeb Daily News - Almac Diagnostics Sees Benefit for Test Pipeline in New Ovarian, Breast Cancer Studies
June 7, 2011 / BioArray News - UM Team Partners with Almac Diagnostics to Study Breast Cancer in African-American Women
August 4, 2009 / BioArray News - Affymetrix to Distribute Almac's Xcel Array for Biomarker Discovery
April 3, 2012 / BioArray News - Almac Dx Plans to Debut Array-based Colorectal Cancer-Recurrence Test Next Year
November 15, 2011 / BioArray News